Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 223

1.

The reasons for use of cannabinoids and stimulants in patients with schizophrenia.

Simonienko K, Wygnał N, Cwalina U, Kwiatkowski M, Szulc A, Waszkiewicz N.

Psychiatr Pol. 2018 Apr 30;52(2):261-273. doi: 10.12740/PP/68472. Epub 2018 Apr 30. English, Polish.

2.

The Cognitive Screening Scale for Schizophrenia (CSSS) - Part 2: Validity of the Scale.

Mosiołek A, Gierus J, Koweszko T, Nowakowska A, Szulc A.

Psychiatr Pol. 2018 Apr 30;52(2):241-250. doi: 10.12740/PP/OnlineFirst/69101. Epub 2017 Jun 29. English, Polish.

3.

The Cognitive Screening Scale for Schizophrenia (CSSS). Part 1. Design and structure of the scale.

Mosiołek A, Gierus J, Koweszko T, Borkowska A, Janus M, Szulc A.

Psychiatr Pol. 2018 Apr 30;52(2):227-239. doi: 10.12740/PP/OnlineFirst/64831. Epub 2017 Feb 10. English, Polish.

4.

"Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders.

Rudzki L, Szulc A.

Front Psychiatry. 2018 May 29;9:205. doi: 10.3389/fpsyt.2018.00205. eCollection 2018. Review.

5.

Evaluation of the relationship between cognitive functioning in patients with borderline personality disorder and their general functioning.

Mosiołek A, Gierus J, Koweszko T, Szulc A.

Psychiatr Pol. 2018 Feb 28;52(1):33-44. doi: 10.12740/PP/OnlineFirst/62657. Epub 2018 Feb 28. English, Polish.

6.

How do patients perceive ambulatory psychiatric care and what are their needs?

Małus A, Galińska-Skok B, Konarzewska B, Szulc A.

Ann Agric Environ Med. 2018 Mar 14;25(1):90-94. doi: 10.5604/12321966.1233559. Epub 2017 Feb 11.

7.

Serum Exoglycosidases in Children and Adolescents With Harmful Alcohol Use.

Waszkiewicz N, Olański W, Chojnowska S, Kołakowska U, Plewa K, Mielech W, Bagniuk-Plewa A, Wasilewska A, Szulc A, Szajda SD, Zwierz K.

J Addict Med. 2018 Jul/Aug;12(4):329-335. doi: 10.1097/ADM.0000000000000411.

PMID:
29570478
8.

Proton magnetic resonance spectroscopy changes after lithium treatment. Systematic review.

Szulc A, Wiedlocha M, Waszkiewicz N, Galińska-Skok B, Marcinowicz P, Gierus J, Mosiolek A.

Psychiatry Res Neuroimaging. 2018 Mar 30;273:1-8. doi: 10.1016/j.pscychresns.2018.01.001. Epub 2018 Jan 17. Review.

PMID:
29414126
9.

Assessment of dietary habits and nutritional status of depressive patients, depending on place of residence.

Stefanska E, Wendołowicz A, Cwalina U, Kowzan U, Konarzewska B, Szulc A, Ostrowska L.

Ann Agric Environ Med. 2017 Dec 23;24(4):581-586. doi: 10.5604/12321966.1233554. Epub 2017 May 11.

10.

Salivary immune proteins monitoring can help detection of binge and chronic alcohol drinkers: Preliminary findings.

Waszkiewicz N, Galińska-Skok B, Zalewska A, Szajda SD, Zwierz K, Więdłocha M, Szulc A.

Drug Alcohol Depend. 2018 Feb 1;183:13-18. doi: 10.1016/j.drugalcdep.2017.10.016. Epub 2017 Dec 1.

PMID:
29222991
11.

Institutional discrimination against psychiatric patients in Poland.

Gierus J, Mosiołek A, Koweszko T, Szulc A.

Lancet Psychiatry. 2017 Oct;4(10):743. doi: 10.1016/S2215-0366(17)30363-2. No abstract available.

PMID:
28946949
12.

Biodiversity of soil bacteria exposed to sub-lethal concentrations of phosphonium-based ionic liquids: Effects of toxicity and biodegradation.

Sydow M, Owsianiak M, Framski G, Woźniak-Karczewska M, Piotrowska-Cyplik A, Ławniczak Ł, Szulc A, Zgoła-Grześkowiak A, Heipieper HJ, Chrzanowski Ł.

Ecotoxicol Environ Saf. 2018 Jan;147:157-164. doi: 10.1016/j.ecoenv.2017.08.026. Epub 2017 Sep 14.

PMID:
28843187
13.

Immune suppression of IgG response against dairy proteins in major depression.

Rudzki L, Pawlak D, Pawlak K, Waszkiewicz N, Małus A, Konarzewska B, Gałęcka M, Bartnicka A, Ostrowska L, Szulc A.

BMC Psychiatry. 2017 Jul 24;17(1):268. doi: 10.1186/s12888-017-1431-y.

14.

Long-term changes of salivary exoglycosidases and their applicability as chronic alcohol-drinking and dependence markers.

Waszkiewicz N, Kratz EM, Chojnowska S, Zalewska A, Zwierz K, Szulc A, Szajda SD, Nestsiarovich A, Kapitau A, Kępka A, Ostrowska L, Ferens-Sieczkowska M.

World J Biol Psychiatry. 2017 Jun 29:1-12. doi: 10.1080/15622975.2017.1337221. [Epub ahead of print]

PMID:
28660791
15.

Pro-inflammatory cytokines associated with clinical severity of dry eye disease of patients with depression.

Mrugacz M, Ostrowska L, Bryl A, Szulc A, Zelazowska-Rutkowska B, Mrugacz G.

Adv Med Sci. 2017 Sep;62(2):338-344. doi: 10.1016/j.advms.2017.03.003. Epub 2017 May 13.

PMID:
28511072
16.

Effects of Antipsychotic Administration on Brain Glutamate in Schizophrenia: A Systematic Review of Longitudinal 1H-MRS Studies.

Egerton A, Bhachu A, Merritt K, McQueen G, Szulc A, McGuire P.

Front Psychiatry. 2017 Apr 28;8:66. doi: 10.3389/fpsyt.2017.00066. eCollection 2017. Review.

17.

An Introduction to the Model of Crisis Intervention Procedure for Borderline Patients (CIP-BP): A Case Study.

Koweszko T, Gierus J, Więdłocha M, Mosiołek A, Szulc A.

Arch Psychiatr Nurs. 2017 Jun;31(3):324-328. doi: 10.1016/j.apnu.2016.11.002. Epub 2016 Nov 12.

PMID:
28499576
18.

Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis.

Więdłocha M, Marcinowicz P, Krupa R, Janoska-Jaździk M, Janus M, Dębowska W, Mosiołek A, Waszkiewicz N, Szulc A.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt C):217-226. doi: 10.1016/j.pnpbp.2017.04.026. Epub 2017 Apr 23.

PMID:
28445690
19.

Mechanisms of Internalization of Maltose-Modified Poly(propyleneimine) Glycodendrimers into Leukemic Cell Lines.

Studzian M, Szulc A, Janaszewska A, Appelhans D, Pułaski Ł, Klajnert-Maculewicz B.

Biomacromolecules. 2017 May 8;18(5):1509-1520. doi: 10.1021/acs.biomac.7b00046. Epub 2017 Apr 25.

PMID:
28414464
20.

Isolation of rhamnolipids-producing cultures from faeces: Influence of interspecies communication on the yield of rhamnolipid congeners.

Woźniak-Karczewska M, Myszka K, Sznajdrowska A, Szulc A, Zgoła-Grześkowiak A, Ławniczak Ł, Corvini PF, Chrzanowski Ł.

N Biotechnol. 2017 May 25;36:17-25. doi: 10.1016/j.nbt.2016.12.008. Epub 2016 Dec 30.

PMID:
28043869

Supplemental Content

Loading ...
Support Center